Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale

MT Newswires Live

01/01

(Updates with Pacira's reply in the third paragraph.)

Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.

DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are "exorbitant and unmerited" and that the board has not provided proper fiduciary oversight.

"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders," Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.

Price: 26.15, Change: +0.08, Percent Change: +0.31

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2600703628"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2600703628\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2600703628?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-01 01:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600703628","market":"us","top_or_hot":-1,"title":"Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale","media":"MT Newswires Live","content":"<html><body><p> (Updates with Pacira's reply in the third paragraph.)</p><p>Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.</p><p>DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.</p><p>\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.</p><p>Price: 26.15, Change: +0.08, Percent Change: +0.31</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Pacira Biosciences Shareholder Seeks Board Changes, Pushes for Sale\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-01-01 01:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> (Updates with Pacira's reply in the third paragraph.)</p><p>Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.</p><p>DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.</p><p>\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.</p><p>Price: 26.15, Change: +0.08, Percent Change: +0.31</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2600703628","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600703628","pubTimestamp":1767200441,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacira Biosciences  shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.Price: 26.15, Change: +0.08, Percent Change: +0.31","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PCRX":"Pacira Pharmaceuticals"},"translate_title":"更新：Pacira Biosciences股东寻求董事会变动，推动出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":1},"content_text":"(Updates with Pacira's reply in the third paragraph.)Pacira Biosciences (PCRX) shareholder, DOMA Perpetual Capital Management, said Tuesday that it plans to nominate three independent director candidates at the company's annual meeting in 2026.DOMA said it owns about 6.83% of the company's shares and added that it is also calling for an immediate sale of the company, arguing that executive pay and overall spending are \"exorbitant and unmerited\" and that the board has not provided proper fiduciary oversight.\"Our Board is committed to enhancing long-term shareholder value and we take seriously feedback from our shareholders,\" Pacira Biosciences told MT Newswires, adding that it remains focused on carrying out its 5x30 strategy to drive growth.Price: 26.15, Change: +0.08, Percent Change: +0.31","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}